Skip to main content
. Author manuscript; available in PMC: 2019 Aug 12.
Published in final edited form as: Am J Psychiatry. 2017 Mar 24;174(6):546–556. doi: 10.1176/appi.ajp.2016.16050517

TABLE 2.

Response and Remission Rates in the Intent-to-Treat Last Observation Carried Forward Sample

Outcome Cognitive-
Behavioral
Therapy (N=105)
Escitalopram
(N=105)
Duloxetine
(N=106)
Total Sample
(N=316)




N % N % N % N %

Non-responsea 32 30.5 26 24.8 21 19.8   79 25.0
Partial responseb 19 18.1 12 11.4 16 15.1   47 14.9
Response without remissionc 10   9.5 18 17.1 11 10.4   39 12.3
Remissiond 44 41.9 49 46.7 58 54.7 151 47.8
a

Endpoint Hamilton Depression Rating Scale (HAM-D) score <30% improved from baseline.

b

Endpoint HAM-D score 30%−49% improved from baseline.

c

Endpoint HAM-D score ≥50% reduction from baseline, without meeting remission criteria.

d

HAM-D score ≤7 at both week 10 and week 12 visits. (or final two ratings visits for noncompleters in the last observation carried forward sample).